BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23859303)

  • 41. Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1-2 hypertension.
    White WB; Littlejohn TW; Majul CR; Oigman W; Olvera R; Seeber M; Schumacher H; Mancia G
    Blood Press Monit; 2010 Aug; 15(4):205-12. PubMed ID: 20613496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination therapy of amlodipine/benazepril versus monotherapy of amlodipine in a practice-based setting.
    Messerli FH; Weir MR; Neutel JM
    Am J Hypertens; 2002 Jun; 15(6):550-6. PubMed ID: 12074358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study.
    Ma L; Wang W; Zhao Y; Zhang Y; Deng Q; Liu M; Sun H; Wang J; Liu L
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):137-42. PubMed ID: 22329591
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of benazepril and hydrochlorothiazide, given alone and in low- and high-dose combinations, on blood pressure in patients with hypertension.
    Chrysant SG; Fagan T; Glazer R; Kriegman A
    Arch Fam Med; 1996 Jan; 5(1):17-24; discussion 25. PubMed ID: 8542050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the dose-response relationship of amlodipine and losartan combination in patients with essential hypertension: an 8-week, randomized, double-blind, factorial, phase II, multicenter study.
    Park CG; Youn HJ; Chae SC; Yang JY; Kim MH; Hong TJ; Kim CH; Kim JJ; Hong BK; Jeong JW; Park SH; Kwan J; Choi YJ; Cho SY
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):35-47. PubMed ID: 22217192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes.
    Winer N; Folker A; Murphy JA; Hung E; Bard M; Perkelvald A; Sowers JR; Bakris GL
    Prev Cardiol; 2005; 8(2):87-92. PubMed ID: 15860983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of aliskiren and amlodipine combination therapy in patients with hypertension: a randomized, double-blind, multifactorial study.
    Littlejohn TW; Jones SW; Zhang J; Hsu H; Keefe DL
    J Hum Hypertens; 2013 May; 27(5):321-7. PubMed ID: 23076450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy.
    Brachmann J; Ansari A; Mahla G; Handrock R; Klebs S
    Adv Ther; 2008 May; 25(5):399-411. PubMed ID: 18465097
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting.
    Sapienza S; Sacco P; Floyd K; DiCesare J; Doan QD
    Clin Ther; 2003 Jun; 25(6):1872-87. PubMed ID: 12860503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and tolerability of candesartan cilexetil/hydrochlorothiazide and amlodipine in patients with poorly controlled mild-to-moderate essential hypertension.
    Fogari R; Mugellini A; Derosa G;
    J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):139-44. PubMed ID: 17907102
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study.
    Kjeldsen SE; Jamerson KA; Bakris GL; Pitt B; Dahlöf B; Velazquez EJ; Hua TA; Kelly RY; Zappe D; Hester A; Tuomilehto J; Ostergren J; Ibsen H; Weber M;
    Blood Press; 2012 Apr; 21(2):82-7. PubMed ID: 21830844
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension.
    Chrysant SG
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):887-95. PubMed ID: 19673666
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized, double-blind trial comparing the effects of amlodipine besylate/benazepril HCl vs amlodipine on endothelial function and blood pressure.
    Mohler ER; Herrington D; Ouyang P; Mangano C; Ritter S; Davis P; Purkayastha D; Gatlin M; Vogel RA;
    J Clin Hypertens (Greenwich); 2006 Oct; 8(10):692-8. PubMed ID: 17028482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized, comparative, multicentric evaluation of atenolol/amlodipine combination with atenolol alone in essential hypertensive patients.
    Pareek A; Salkar H; Mulay P; Desai S; Chandurkar N; Redkar N
    Am J Ther; 2010; 17(1):46-52. PubMed ID: 19535971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination therapy with amlodipine/valsartan in essential hypertension: a 52-week, randomised, open-label, extension study.
    Smith TR; Glazer RD; Koren MJ; Wernsing M; Zhang Y
    Int J Clin Pract; 2010 Sep; 64(10):1367-74. PubMed ID: 20716145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy.
    Taylor AA; Shoheiber O
    Congest Heart Fail; 2003; 9(6):324-32. PubMed ID: 14688505
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fixed combination of benazepril and low-dose amlodipine in the treatment of mild to moderate essential hypertension: evaluation by 24-hour noninvasive ambulatory blood pressure monitoring.
    Fogari R; Zoppi A; Lusardi P; Mugellini A; Preti P; Motolese M
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):176-81. PubMed ID: 9269944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.